This result is consistent with previous evidence in the non-COVID-19 literature, which indicates that CRP independently predicts delirium [25,26,27], and with recent findings in COVID-19 patients suggesting an association between CRP levels and delirium occurrence [28]. The gene discussed is CRP; the disease is delirium.